Publication: A liquid chromatographic-Tandem mass spectrometric method for determination of artemether and its metabolite dihydroartemisinin in human plasma
Issued Date
2009-01-01
Resource Type
ISSN
17576199
17576180
17576180
DOI
Other identifier(s)
2-s2.0-70349178524
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Bioanalysis. Vol.1, No.1 (2009), 37-46
Suggested Citation
Warunee Hanpithakpong, Benjamas Kamanikom, Pratap Singhasivanon, Nicholas J. White, Nicholas P J Day, Niklas Lindegardh A liquid chromatographic-Tandem mass spectrometric method for determination of artemether and its metabolite dihydroartemisinin in human plasma. Bioanalysis. Vol.1, No.1 (2009), 37-46. doi:10.4155/bio.09.6 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/27339
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
A liquid chromatographic-Tandem mass spectrometric method for determination of artemether and its metabolite dihydroartemisinin in human plasma
Other Contributor(s)
Abstract
Background: Artemether-lumefantrine is the most widely recommended artemisinin-based combination treatment for falciparum malaria. Quantification of artemether and its metabolite dihydroartemisinin in biological matrices has traditionally been difficult, with sensitivity being an issue. Results: A high-throughput bioanalytical method for the analysis of artemether and its metabolite dihydroartemisinin in human plasma using solid-phase extraction in the 96-well plate format and liquid chromatography coupled to positive ion mode tandem mass spectroscopy has been developed and validated according to US FDA guidelines. The method uses 50 μl plasma and covers the calibration range 1.43-500 ng/ml with a limit of detection at 0.36 ng/ml. Conclusions: The developed liquid chromatography-tandem mass spectrometry assay is more sensitive than all previous methods despite using a lower plasma volume (50 μl) and is highly suitable for clinical studies where plasma volumes are limited, such as pediatric trials. © 2009 Future Science Ltd.